Because our products are designed and built with system integration in mind, no matter which type of oral solid dosage (OSD) form you need to produce, we can help you to select the optimal solution.
By embracing digitalization, modularization, holistic product innovation and sustainability, we can supply both standard and custom-configured lines to suit specific projects. For example, fluid bed dryers and coaters can be combined with top- or bottom-drive high shear mixer/granulators, wet and dry milling facilities, product handling systems, binder and coating preparation units, filtration units and/or tablet presses. Furthermore, safety, containment, product flow and building requirements are fully incorporated for optimum process efficiency.
With a stronger focus on efficiency, Industry 4.0 and the environment, the pharmaceutical industry is evolving. GEA is committed to transforming tomorrow with better processes and has enthusiastically embraced these themes. For example, when the industry embraced continuous manufacturing to improve efficiencies and product quality, GEA was already bringing process-ready technology to the market.
And when it comes to digitalization, we’ve been innovating for years and bringing new services to customers, such as our virtual reality (VR)-based training modules. Ongoing product innovation, making our equipment better for the user and the planet, ensures that when you invest in a GEA process line, you’re making the right choice.
Отображение 4 из 27
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Изменение климата и растущее население планеты оказывают повышенное давление на энергоемкую пищевую промышленность, чтобы накормить больше людей и при этом не нанести вред планете. Джордж Шеперд, менеджер по глобальной технической устойчивости компании GEA, объясняет, как компания GEA использует свои инженерные ноу-хау, чтобы помочь переработчикам производить продукцию более устойчиво и при этом повысить производительность.
The world's population is growing and with it demand for milk. Dairy is an essential component of many global diets. However, its production can be resource-intensive and impact the environment. GEA’s Christian Müller, Senior Director Sustainability Farm Technologies, sheds light on how technological innovations powered by GEA make milk production more efficient and profitable.
Каждый безопасный для употребления напиток и пищевой продукт — это победа над невидимыми микробными угрозами — борьба, которая ведется в течение уже ста лет разработки и проектирования технологических процессов, отвечающих требованиям гигиенических норм. Обладая более чем 100-летним опытом и уникальными знаниями в области проектирования и гигиенического проектирования, компания GEA устанавливает отраслевые стандарты для технологического оборудования, задачей которого является защита продуктов питания и спасение жизней людей.